National Comprehensive Cancer Network



About NCCN

Central Nervous System Cancers Panel - Disclosures as of 2/13/2012

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty Spouse/Domestic Partner/Dependent Potential Conflict Attendance

Mario Ammirati, MD, MBA

None

None

None

None

None

Philip J. Bierman, MD

None

None

None

None

None

Henry Brem, MD

None

None

None

None

None

Nicholas Butowski, MD

None

None

None

None

None

Marc C. Chamberlain, MD

NCCN Funded Bendamustine trial for Recurrent High-Grade Gliomas

Enzon Pharmaceuticals;
Exelixis Inc.;
Genentech, Inc.;
Schering-Plough Corporation

None

None

None

Lisa M. DeAngelis, MD

None

Genentech, Inc.

None

None

None

Robert A. Fenstermaker, MD

None

None

None

None

None

Allan Friedman, MD

None

None

None

None

None

Lauren Gallagher, RPh, PhD

None

None

None

None

None

Mark R. Gilbert, MD

RTOG Trial

Abbott Laboratories;
Genentech, Inc.;
Merck & Co., Inc.;
Pfizer Inc.;
Schering-Plough Corporation

None

None

None

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

None

Deneen Hesser, MSHSA, RN, OCN

None

None

None

None

None

Maria Ho, PhD

None

None

None

None

None

Matthias Holdhoff, MD, PhD

None

None

None

None

None

Larry Junck, MD

None

None

None

None

None

Gerald P. Linette, MD, PhD

None

Bristol-Myers Squibb Company;
Genentech, Inc.;
GlaxoSmithKline

None

None

None

Jay S. Loeffler, MD

None

None

None

None

None

Moshe H. Maor, MD

None

None

None

None

None

Joan S. McClure, MS

None

None

None

None

None

Nicole McMillian, MS

None

None

None

None

None

L. Madison Michael, II, MD

None

None

None

None

None

Paul L. Moots, MD

None

None

None

None

None

Tara Morrison, MD, FRCPC

None

Merck & Co., Inc.

None

None

None

Maciej M. Mrugala, MD, PhD, MPH

None

Enzon Pharmaceuticals;
Schering-Plough Corporation

None

None

None

Louis Burt Nabors, MD

AstraZeneca Pharmaceuticals LP;
Boehringer Ingelheim GmbH;
Eli Lilly and Company;
Genentech, Inc.;
GlaxoSmithKline;
ImClone Systems Incorporated;
Merck KGaA;
Transmolecular

Merck KGaA

None

None

None

Herbert B. Newton, MD

None

Eisai Inc.;
UCB Pharma;
Schering-Plough Corporation

None

None

None

Jana Portnow, MD

None

None

None

None

None

Jeffrey J. Raizer, MD

None

Enzon Pharmaceuticals;
Genentech, Inc.;
Merck & Co., Inc.;
Merck & Co., Inc.;
Geron

None

None

None

Lawrence Recht, MD

None

Genentech, Inc.

None

None

None

Dennis C. Shrieve, MD, PhD

None

None

None

None

None

Allen K. Sills, MD

None

Merck & Co., Inc.

None

None

None

Nam Tran, MD, PhD

None

None

None

None

None

Frank D. Vrionis, MD, MPH, PhD

None

Florida Board of Medicine;
Orthofix;
Southeastern Brain Tumor Association

None

None

None

Patrick Yung Wen, MD

None

Genentech, Inc.

None

None

None